0002058052-26-000004.txt : 20260603 0002058052-26-000004.hdr.sgml : 20260603 20260603122807 ACCESSION NUMBER: 0002058052-26-000004 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260603 DATE AS OF CHANGE: 20260603 EFFECTIVENESS DATE: 20260603 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Maxymune Therapeutics, Inc. CENTRAL INDEX KEY: 0002058052 ORGANIZATION NAME: EIN: 933707815 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-539494 FILM NUMBER: 261059742 BUSINESS ADDRESS: STREET 1: 95 MAIN ST. STREET 2: SUITE 9 CITY: LOS ALTOS STATE: CA ZIP: 94022 BUSINESS PHONE: 650-892-1942 MAIL ADDRESS: STREET 1: 95 MAIN ST. STREET 2: SUITE 9 CITY: LOS ALTOS STATE: CA ZIP: 94022 D/A 1 primary_doc.xml X0708 D/A LIVE 0002058052 Maxymune Therapeutics, Inc. 95 MAIN ST. SUITE 9 LOS ALTOS CA CALIFORNIA 94022 650-892-1942 DELAWARE Transplant RX, Inc. None Corporation true 2023 Gordon Ringold 1744 GROUSE RIDGE RD Truckee CA CALIFORNIA 96161 Executive Officer Director Neil Solomons 5553 PARKER AVE Victoria A1 BRITISH COLUMBIA, CANADA V8Y 2N2 Director Tatjana Naranda 27343 URSULA LANE Los Altos CA CALIFORNIA 94022 Executive Officer Director Biotechnology No Revenues 06b true 0002058052-25-000003 2025-02-11 true true false 10000 4500000 2675000 1825000 false 15 0 0 0 false Maxymune Therapeutics, Inc. Tatjana Naranda Tatjana Naranda President & COO 2026-06-03